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Background: The liver plays an essential role in the body by regulating several important metabolic functions.
Liver injury is associated with the distortion of these functions causing many health problems. Pharmaceutical drugs
treat liver disorders but cause further damage to it. Hence, herbal drugs are used worldwide and are becoming
increasingly popular.
Methods: The hepatoprotective activity of Phyllanthus niruri (PN) was evaluated against liver cirrhosis induced
by thioacetamide (TAA) in male Sprague Dawley rats. Rats received intraperitoneal injections of thioacetamide
(TAA, 200 mg/kg, b.w. three times weekly) for eight weeks. Daily treatments with plant extract (200 mg/kg) were
administered orally for eight weeks. At the end of the study, hepatic damage was evaluated by monitoring
transforming growth factor (TGFβ), collagen α1 (Collα1), matrix metalloproteinase-2 (MMP2) and tissue inhibitor of
matrix metalloproteinase-1 (TIMP1) gene expression by real-time PCR. Moreover, different chromatographic
techniques including column chromatography, thin layer chromatography, and Ultra Performance Liquid
Chromatography (UPLC) with Liquid Chromatography/Mass Spectrometry (LC/MS) were used to isolate the active
constituents of the plant.
Results: The results revealed that treatment with PN significantly reduced the effect of thioacetamide toxicity and
exhibited effective hepatoprotective activity. The mechanism of the hepatoprotective effect of PN is proposed to be
by normalizing ROSs. Additionally, PN treatment regulated the expression of TGFβ, Collα1, MMP2, and TIMP1 genes.
In the active fraction of P. niruri, the isolated chemical constituents were 4-O-caffeoylquinic acid and quercetin
3-O-rhamnoside.
Conclusions: The results of the present study indicate that PN ethanol extracts possess hepatoprotective activity
that is most likely because of the isolated chemical constituents.
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Phyllanthus niruri has been used in folk medicine as an
antipyretic, analgesic, or anti-inflammatory treatment,
and treatment of other symptoms suggests antihistamine
effects. Moreover, the decoction of the whole plant
has been used orally against diarrhea and topically to
treat jaundice. Crushed leaves together with leaves of
Eupatorium odoratum and lime are applied on boils [1].
Previous studies have revealed the therapeutic potential
of Phyllanthus niruri to treat genitourinary infections,
venereal diseases, and kidney or bladder stones. More-
over, P. niruri is reported to act as a urinary inhibitor of
calcium oxalate crystallization and an effective treatment
for urolithiasis by interfering in the growth and aggrega-
tion of calcium oxalate crystals [2-4]. The reported anti-
hyperuricemic action might be because of its uricosuric
activity through an xanthine oxidase inhibitory effect [5].
Many reports in the literature have verified the pro-
tective activity of Phyllanthus niruri against various
drug- and toxin-induced hepatic disorders. Earlier stud-
ies [6] have shown that extracts of P. niruri have demon-
strated hepatoprotective activity against the carbon
tetrachloride induced lipid peroxidation in the livers of
rats, which was determined by raised serum enzyme
levels. Although the effects of aqueous extracts of P. niruri
against carbon tetrachloride (CCL4)-induced liver, kidney
and testes injuries have been studied [7], Manjrekar et al.
concluded that the hepatoprotective and antioxidant acti-
vity of this plant was associated with adverse effects on
kidney and testes. In the study by Bhattacharjee et al. [8],
the hepatoprotective potential of the protein isolated from
P. niruri against CCL4-induced liver damage was investi-
gated. These results suggested that this protein protected
the liver against oxidative stress and stimulated liver repair
mechanisms. Additionally, Harish et al. [6] investigated
the antioxidant activity of extracts of P. niruri against
CCL4-induced liver damage. They demonstrated that
membrane lipid peroxidation (LPO) inhibition was con-
firmable by pre-treatment with the extracts.
In our previous research, we proved that P. niruri pos-
sesses hepatoprotective activity against thioacetamide-
induced liver cirrhosis. Acute toxicity was studied, and the
results demonstrated that P. niruri extract was non toxic
when applied to SD rats. Significant differences were ob-
served between thioacetamide-treated rats (200 mg/kg)
and high or low dose (200 mg/kg and 100 mg/kg)
P. niruri-treated rats in the body and liver weights, total
antioxidant capacity, liver biochemical parameters, oxida-
tive stress enzyme and lipid peroxidation levels. Moreover,
P. niruri treatment effectively restored the histological and
morphological observations closer to their normal appea-
rances [9].
The goal of this study was to study the mechanism
that induces the hepatoprotective activity of Phyllanthusniruri ethanol extract in protecting liver cirrhosis
induced by thioacetamide in Sprague Dawley rats
by monitoring the expression of transforming growth
factor beta (TGFβ1), tissue inhibitors of metalloproteinases
(TIMP1), matrix metalloproteinase (MMP2), and collagen
alpha (Collα1) gene expression by real-time PCR. More-
over, the active constituents of the Phyllanthus niruri were
isolated by separating the crude extract into several frac-
tions using flash column chromatography and thin layer
chromatography. Subsequently, the immunomodulatory ac-
tivity for all fractions was tested to examine their abilities to
proliferate human peripheral blood mononuclear cells
(PBMCs). LC/MS was performed on the fraction that
exhibited higher proliferation activity on the PBMCs.
Methods
Preparation of plant extract
Phyllanthus niruri plant was gained from Ethno Re-
sources Sdn Bhd, identified and a voucher specimen
(voucher number KLU46618) was kept. By the method
of Zahra et al. [10], a crude ethanol extract was prepared
by drenching 100 g of it in 1000 mL of 95% ethanol
(1:10 w/v) for 72 hours at 25°C. The mixture was filtered
and distilled under reduced pressure at 45°C by a rotary
evaporator. The crude extract was maintained at −20°C
until further experiments were done.
Chemicals and apparatus
In brief, 95% (v/v) ethanol, filter paper (Whatman No. 1),
Thioacetamide, xylazine, ketamine, formalin, hematoxylin,
and eosin were purchased from Sigma-Aldrich (Gillingham,
UK). RNAlater solution (Applied Biosystems, Foster
City, CA, USA), QIAamp RNA blood mini kit (Qiagen,
Germantown, MD, USA), RNase-free DNase set (Qiagen),
agarose gels, Tris-borate-EDTA (10× TBE) (Applied
Biosystems), ethidium bromide, loading dye (Promega,
Madison, WI, USA) and a UV gel documentation system
(Vilber Lourmat, Fisher Scientific Sdn Bhd). High Capacity
RNA-to-cDNA Master Mix, TaqMan Fast Advanced Mas-
ter Mix, ultrapure DNase-free water (Applied Biosystems)
were used to perform the reverse transcription and
real-time PCR. Transforming growth factor beta (TGFβ1),
tissue inhibitors of metalloproteinases (TIMP1), matrix
metalloproteinase (MMP2), collagen alpha (Collα1),
hypoxanthine phosphoribosyltransferase 1 (Hprt1), and
peptidylprolyl isomerase A (Ppia) were the genes of interest.
Silica gel 60 powder (0.063–0.200 mm, 70–230 mesh),
silica gel F254 plates (20 × 20 cm, 0.2 mm), HPLC grade
n-hexane, HPLC grade ethyl acetate, HPLC grade
methanol, HPLC grade acetonitrile were purchased from
(Merck, Germany), a Kontes column (2 × 30 cm) with an
EYEL-4 pump (Rikakikai, Tokyo, Japan) and a Milli-Q
water purification system (Millipore, Billerica, MA,
USA) were used to perform the HPLC analysis.
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The animal protocol was agreed by the Ethics Commit-
tee for Animal Experimentation, Medicine Faculty, Uni-
versity Malaya, Kuala Lumpur, Malaysia, under Ethic
number PM/28/08/2010/MAA (R). The animals were
cared for according to the “Guide for the Care and Use
of Laboratory Animals”, published by the National Aca-
demy of Science. The animals were provided with water
and standard pellet ad libitum.
Sprague Dawley rats (24 male) weighing 190–260
grams were divided into 3 groups randomly of 8 rats
each. The experimental groups were as follows: healthy
controls (vehicle control group), thioacetamide controls
(liver cirrhosis control), and the P. niruri treatment
group. The plant extract was suspended in Tween 20
(10%) and administered by oral gavage (5 mL/kg body
weight). Thioacetamide was suspended in dH2O (2 mL/kg
body weight) and injected intraperitoneally to the rats.
Group no. 1 (normal group) treated daily with Tween 20
orally and injected with dH2O three times weekly intra-
peritoneally (ip) for two months. Group no. 2 (TAA
group) treated daily with Tween 20 and injected with
TAA (200 mg/kg) three times weekly for two months.
The above mentioned procedure was following the
method of Alshawsh et al. [11]. Group no. 3 (PN-treated
group) treated daily with the PN extract (200 mg/kg) orally
and injected with TAA (200 mg/kg) three times weekly
for two months.
Sample collection
After two months, each rat was fasted for 24 hours prior
to sacrificing. A perfusion was performed under keta-
mine and xylazine (1:10 v/v) anesthesia, and rats were
quickly sacrificed by exsanguination of the jugular vein.
A small portion of the livers were kept immediately in
an RNAlater solution (Applied Biosystems) for gene ex-
pression analysis and kept at −80°C until the purification
experiment was performed. The gene expression assays
were performed using the following TaqMan gene ex-
pression workflow: RNA isolation and purification, RNA
transcription RNA to cDNA, and amplification of cDNA
and target genes by real-time PCR. The gene assays
used in this study were transforming growth factor
beta (TGFβ1), tissue inhibitors of metalloproteinases
(TIMP1), matrix metalloproteinase (MMP2), and collagen
alpha (Collα1), and hypoxanthine phosphoribosyltransferase
1 (Hprt1) and peptidylprolyl isomerase A (Ppia) were used
as housekeeping genes.
Gene expression profile
RNA isolation and purification
RNA was extracted from the frozen liver using a QIAamp
RNA Blood Mini Kit following the manufacturer’s protocol.
Briefly, 30 mg of frozen RNAlater-stabilized liver tissue wasweighed immediately (without allowing the tissue to thaw),
then disrupted and grinded by using a mortar and pestle.
QIAshredder spin columns were used for homogenization
and separation of the tissue lysates. The column digestion
of DNA was performed during RNA purification using an
RNase-free DNase set according to the manufacturer’s in-
structions. Finally, total RNA was stored at −70°C until
further use.
RNA purity was quantified using a spectrophotometer
using a 10 mm quartz cuvette. With a 40× dilution fac-
tor, absorbance was measured at 230, 260, 280, and
320 nm, and the following ratios were calculated: 260/
280 and 260/320.
RNA integrity was measured by agarose gels electro-
phoresis. Electrophoresis buffer tris-borate-EDTA (10×
TBA) was prepared to fill the electrophoresis tank and
cast the gel. A 0.5% (w/v) solution of agarose in electro-
phoresis buffer was prepared. Ethidium bromide was
added to the molten gel to a final concentration (0.5 μg/
mL) and then mixed thoroughly by gentle swirling. A
small-toothed comb (allows 1 μL sample/well) was posi-
tioned on the plate to form complete wells. The 60°C
agarose solution was poured into the mold and allowed
to set at room temperature for 30–45 minutes. The gel
was mounted into the tank, and the electrophoresis buf-
fer was added to cover the gel at a depth of 1 mm.
RNA samples (1 μL each) were loaded after mixing with
the loading dye. Subsequently, the RNAs were allowed to
migrate toward the positive anode. The gel ran for 30 mi-
nutes at 95 V until the migrated distance was 75% through
the gel. The gels were examined under UV light to observe
the discrete 18S and 28S ribosomal RNA bands.
Reverse transcription of RNA to cDNA
cDNA was synthesized using High Capacity RNA-to-cDNA
Master Mix in a reaction plate according to the manufac-
turer’s instructions.
Amplification of cDNA by real-time PCR
Real-time PCR was performed using a StepOnePlus Sys-
tem and TaqMan Fast Advanced Master Mix (Applied
Biosystems). The total reaction volume (10 μL) consisted
of the following: 1 μL cDNA (20 ng), 5 μL TaqMan Fast
Advanced Master Mix, 0.5 μL of each TaqMan Gene Ex-
pression Assay, and 3.5 μL ultrapure DNase-free water.
The cycle parameters were as follows: UNG incubation
at 50°C for 2 min, polymerase activation at 95°C for
20 s, denaturation at 95°C for 1 s and then annealing
and extension at 60°C for 20 s.
Real-time PCR data normalization
The real-time PCR work was done in triplicate for each
sample. Two endogenous control genes, hypoxanthine
phosphoribosyltransferase 1 (Hprt1) and peptidylprolyl
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comparative CT method was used to calculate to calcu-
late the relative amount of the transcripts in all groups,
and genes were normalized to the endogenous controls.
The final value was normalized to the Hprt1 and Ppia
genes and qualified to the normal control values of the
investigated genes. The formula is as follows:
ΔΔCT ¼ ΔCT sampleð Þ−ΔCT normalð Þ
Where ΔCT is the difference in CT between the targeted
gene and housekeeping controls by minimizing the average
CT of the controls. The fold-change calculated as: 2-ΔΔCT.
Chromatography profile
Flash column chromatography (FCC)
Plant fractionations were performed following the method
of Fraga et al. [12]. Flash column chromatography was
performed on silica gel 60 (0.063–0.200 mm, 70–230 mesh)
from (Merck, Germany) using a Kontes column (2 ×
30 cm) with an EYEL-4 pump (Rikakikai, Tokyo, Japan).
The elution process to extract plant fractions (1 g/5 mL
methanol) began with the most non-polar solvent (n-hex-
ane), and then a continuous gradient elution (n-hexane –
ethyl acetate – methanol – acetonitrile) was applied that
concluded with the most polar solvent (dH2O), which was
purified by a Milli-Q water purification system (Millipore).
Thin layer chromatography (TLC)
The obtained fractions were dissolved in methanol at
10 mg/mL to perform thin layer chromatography (TLC)
with silica gel F254 (20 × 20 cm, 0.2 mm) plates. The
analyses were achieved in the following: n-hexane –
ethyl acetate, ethyl acetate – methanol, methanol –
acetonitrile, and acetonitrile – water.
Ultra Performance Liquid Chromatography (UPLC) and
Liquid Chromatography/Mass Spectrometry (LC/MS)
A Waters Synapt HDMS system in TOF-mode was used to
perform Ultra Performance Liquid Chromatography (UPLC)Figure 1 A typical ethidium bromide-stained agarose gel shows the i
Lourmat gel documentation system (B) visualized under UV light.and HDMS-mode was used to perform mass spectrometry
that was equipped with an ACQUITY PDA Detector and
ACQUITY UPLC BEH C18 column (1.7 μm, 2.1 × 50 mm).
The flow rate was 0.5 mL/min, and the injection volume
was 3 μL. The analyses were performed using binary gra-
dients of Milli-Q water (with 0.1% formic acid) (solvent A)
and HPLC grade acetonitrile (with 0.1% formic acid) (solv-
ent B) with the following elution profile: from 0 min: 0%
(B) in (A); 7 min: 100% (B) in (A); 10 min: 100% (B) in
(A); 11 min: 0% (B) in (A).Statistical analysis and data management
Real-time PCR data were analyzed using GenEx pro-
gram. (GenEx software, www.multid.se); fold changes
were calculated, and T-test was used to examine the dif-
ferences between groups for all genes. “The Dictionary
of Natural Products on DVD” software (CRC Press, Tay-
lor and Francis Group, www.netbeans.org) was used to
analyze the chromatography profiling data.Results
Integrity of RNA
Total RNA was extracted from the liver tissues, and the
quantity of RNA was determined by reading the absorb-
ance at 260 nm spectrophotometrically with an ND-
2000 NanoDrop Spectrophotometer (Thermo Fisher Sci-
entific, Wilmington, DE, USA). The ratio of the absor-
bance readings at 260 nm and 280 nm was used to
indicate the quality of RNA. The 260/280 ratio for our
RNA preparation ranged from 1.6–2.1; these values sug-
gested good quality RNA. The integrity of RNA was
checked by agarose gel electrophoresis. Discrete 28S and
18S ribosomal RNA bands were obtained in each case.
The 28S rRNA band was approximately twice as large as
the 18S rRNA band, indicating that the extracted RNA
was intact and could be used in RT-PCR. Figure 1 shows
a typical ethidium bromide-stained agarose RNA gel.ntegrity of the extracted RNA; (A) visualized under a Vilber
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Ct values of real-time PCR data were calculated using
GenEX software and normalized to the reference genes
HPRT1 and Ppia. The analysis showed significant diffe-
rences in mRNA expression levels of the investigated
genes between the controls and TAA- and PN-treated
rats. In the control rats, the mRNA levels of TGFβ,
collα1, MMP2 or TIMP1 were unchanged suggesting
that the hepatic satellite cells (HSCs) were in their qui-
escent state (Figure 2). In the TAA-treated group, hep-
atic expression levels of all investigated genes were
upregulated. The upregulation was significant at (P <
0.01) in the TAA-treated group compared with the PN-
treated group for the genes TGFβ (1.677 ± 0.120),
Collα1 (47.062 ± 7.716) and MMP2 (14.500 ± 3.528).
However, the difference was non-significant for TIMP1
(1.738 ± 0.486).
Oral administration of PN before cirrhosis induction
prevented and resolved the activation of HSCs, and theFigure 2 Real-time PCR analysis shows the relative fold changes of tr
(MMP2), tissue inhibitors of metalloproteinases 1 (TIMP1), and collage
expressed as the mean ± S.E.M. Different superscripts state significant diffe
(b) indicates significance versus the TAA-treated group at P ≤ 0.05 and (c)remaining cells expressed decreased levels of TGFβ,
Collα1, and MMP2 compared with the TAA-treated
group as shown in Figure 2.
Chromatography profile
After crude extraction of P. niruri, the ethanol extract
was objected to flash column chromatography to sepa-
rate the constituents of the extracts according to mo-
lecular size, molecular mass, and polarity. Therefore, 12
fractions were obtained, and by performing thin layer
chromatography, the subsequent fractions with the same
retention factor and spot colors after visualizing under
UV light at 240 nm and 360 nm were combined to yield
five fractions (PNF1, PNF2, PNF3, PNF4, and PNF5).
The best resolutions of plates were given by acetonitrile-
water. Subsequently, the immunomodulatory activity for
all fractions was tested to examine their abilities to pro-
liferate human peripheral mononuclear cells (PBMCs).
As shown in Figure 3, PN fractions showed high activitiesansforming growth factor beta (TGFβ), matrix metalloproteinase 2
n alpha (Collα1) between all experimental groups. Values
rences. (a) Indicates significance versus the Normal group at P ≤ 0.05;
indicates significance versus the TAA-treated group at P ≤ 0.01.
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Figure 3 The effects of P. niruri fractions on human peripheral blood mononuclear cell (PBMC) proliferation. Data are expressed as the
mean ± SEM for triplicates; (*) indicates significance versus the control group (CTRL = dH2O) at P ≤ 0.05.
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tion with the highest activity was PNF1.
LC/MS was performed on the PNF1 fraction, which
exhibited higher activity to proliferate the PBMCs. Sub-
sequently, by LC/MS/MS using the positive ionizationFigure 4 LC-TOF/MS and UV diode array chromatograms of P. niruri f
diode array spectra at a range between 190 and 800 nm (C) TOF/MSmode, four peaks were observed from PNF1 (Figures 4,
5, 6 and Table 1). However, only peak numbers 2 and 4
were identified. Peak number 2 (RT = 4.454 min, λ =
221 and 280 nm, MW= 355) (Figure 5) had [M +H]+
at m/z 356 and was identified as caffeoylquinic acidraction 1 (PNF1); (A) UV diode array spectra at 280 nm (B) UV
peaks in the positive mode ionization.
Figure 5 UV max spectra and mass spectrum (TOF MS ES+) of peak no. 2 in P. niruri F1 (identified as 4-O-caffeoylquinic acid).
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340 (loss of CH3) and predominant fragments at m/z
191,165,151, and 147. Peak number 4 (Figure 6) (RT =
7.96 min, λ = 225 nm, MW= 448) had [M + H-H2O]
+
at m/z 430 and was identified as quercetin 3-O-rhamnoside
with the loss of H2O, and with the loss of rhamnoside,
the ion appeared at m/z 303 and was identified asFigure 6 UV max spectra and mass spectrum (TOF MS ES+) of peak nquercetin with other fragments at m/z 219, 205 and 165
[13,14].
Discussion
The objective of this study was to determine the roles of
transforming growth factor β (TGFβ1), metalloproteinase-2
(MMP2), collagen αI (Collα1) and tissue inhibitor ofo. 4 in P. niruri F1 (identified as quercetin 3-O-rhamnoside).
Table 1 Putative identification of main components of P. niruri’s active fraction
Plant fraction Rt.time (min) λ (nm) Molecular weight [M + H]m/z MS/MS fragmentation Tentative identification Molecular formula
PNF1 4.437 221, 280 355 356 340, 191, 165 , 151, 147 4-O-Caffeolquinic acid C16H18O9
7.92 225 448 430 303, 219, 205, 165 Quercetin3-O-rhamnoside C21H20O11
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induced liver cirrhosis in rats.
These results demonstrated that the mRNA expression
levels of TGFβ1, Collα1, MMP2, and TIMP1 were un-
changed in the control group; this supports the hypothesis
that hepatic satellite cells (HSCs) were still in their quies-
cent state. However, these HSCs were activated by the
presence of TAA and led to the high production of ECM
and consequently high expression of TGFβ, Collα1,
MMP2, and TIMP1.
PN treatment successfully prevented the high synthesis of
ECM and reduced the mRNA expression of TGFβ, Collα1,
and MMP2 compared with the TAA-treated group.
Most studies of human liver diseases and animal
models of progressive fibrosis have demonstrated that
TIMP1 mRNA expression was upregulated at early
stages of fibrosis and because TIMP1 functions not only
reduce MMP activity but also act on the suppression of
apoptosis by HSCs [15]. In our findings, hepatic reduc-
tion in TIMP1 mRNA expression in the TAA-treated
group can be explained as a consequence of increased
HSC apoptosis [16].
Figure 7 shows the putative mechanism of the alter-
ation of mRNA levels of the investigated genes in TAA-Figure 7 Putative mechanism of Phyllanthus niruri hepatoprotective etreated rats. First, TAA bioactivates into thioacetamide-
S-oxide and other ROSs [17,18], and activates the HSCs,
which, in turn releases more ECM and subsequently in-
creases TGFβ gene expression that affects the release of
collagen α and MMP1 and then TIMP1. Therefore, scar
tissue develops, and the liver losses its normal functions,
anatomical shape and architecture [19,20]. Treatment
with PN significantly reduced the effect of thioacetamide
toxicity as follows: 1) removing the causative stimuli of
TAA, neutralizing ROSs by their high antioxidant con-
tent and attenuating endogenous antioxidant enzymes
to their normal levels; 2) maintaining HSCs in their quies-
cent state; and 3) increasing the release of TIMP1 to
counter balance MMP2 and complete remodeling of the
hepatocyte cellular system that preserves or sustains nor-
mal liver function, shape, and appearance.
These findings confirm the previous findings of Wills
and Asha [21] who suggested that the hepatoprotective
role of Lygodium flexuosum plant extract is because
of the reduced mRNA levels of growth factors,
proinflammatory cytokines, and other signaling mole-
cules, which are involved in hepatic fibrosis including
TGFβ1, procollagen-I, and TIMP1. Additionally, Chen
et al. [22] demonstrated the hepatoprotective effects offfect as a response to TAA-induced hepatotoxicity.
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caused by downregulation of hepatic MMP2, TIMP1,
TGFβ1, COLα1 and other genes in the mouse model
of chronic liver fibrosis. Although the antifibrotic and
hepatoprotective properties of the silibinin–phosphat-
idylcholine-vitamin E complex in the rat model of liver
fibrosis stimulated by bile duct ligation and dimethyl-
nitrosamine administration have been postulated to
cause reduced mRNA expression levels of procollagen
type I, TGFβ1, TIMP1, and MMP2, the administration
of the complex has also been reported to reduce hep-
atic stellate cell activation and proliferation with colla-
gen deposition [23].
The isolated chemical constituents included in P. niruri
(4-O-caffeoylquinic acid and quercetin 3-O-rhamnoside)
can further interpret the abovementioned hepatoprotective
activity. 4-O-Caffeoylquinic acid, which is classified as a
tannin, has been isolated previously from P. niruri and
proven to possess antioxidant, immunomodulatory, and
hepatoprotective effects in several in vivo and in vitro assays
[24-26]. However, quercetin 3-O-rhamnoside belongs to
the flavonoid group of compounds that exhibits a wide
range of pharmacological benefits including antimicrobial,
antiviral, antioxidant, gastroprotective, hepatoprotective,
anti-inflammatory and chemopreventive effects [27-30].
Moreover, potential working mechanisms of flavonoids du-
ring injuries and tissue damage include the following: the
interference of ≥3 different free radical producing systems
and an increase in function of the endogenous antioxidants
CAT, SOD, and GPX [31]. Quercetin 3-O-rhamnoside
has been confirmed in Phyllanthus species and other spe-
cies of the Euphorbiaceae family [32-34]. Finally, both iso-
lated chemical compounds from P. niruri (tannins and
flavonoids) are classified as “polyphenols”, which are
one of the most frequent and ever-present groups of
plant metabolites, and have an important role in human
and animal diets [35]. Recent studies have shown that
plant-derived polyphenols are promising nutraceuticals
for the control of various disorders, such as cardiovas-
cular, neurological, and neoplastic diseases [36]. In
addition, plant-derived polyphenolic compounds have
hepatoprotective activity against different types of liver
damage inducers, such as CCL4 [37], paracetamol [38],
and thioacetamide [39], which explains the high interest
and initiation of many studies to evaluate the biological
activity and bioavailabilities of polyphenolic compounds.
Conclusion
This present study contributes significant knowledge to
our understanding of the mechanism that underlies the
hepatoprotective effect of Phyllanthus niruri, which is
suggested to be through the regulation of TGFβ,
Collα1, MMP2, and TIMP1 genes expression. The iso-
lated chemical compounds (4-O-caffeoylquinic acid andquercetin 3-O-rhamnoside) of Phyllanthus niruri might
have direct consequences for hepatoprotective activity.
Therefore, promising approaches from this study must
focus on TGFβ, Collα1, MMP2, and TIMP1 genes ex-
pression to develop new therapy for the treatment of
liver cirrhosis.
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